InvestorsHub Logo
Followers 71
Posts 7941
Boards Moderated 0
Alias Born 01/29/2015

Re: None

Thursday, 04/18/2019 3:59:15 PM

Thursday, April 18, 2019 3:59:15 PM

Post# of 16697
P.S.S. Just how management flipped our name on it's head by first stating Nash was a division of Breathtec, then to eliminate both names and go with Algernon. Kal can simply revise the Breathtec Biomedical name and make it a division of Cannabix or the other way around. The change makes complete sense. The only reason not is simply more insider greed for Kal and pals. Like doing a licensing/partnership deal with the med device that basically provides insiders with royalty fees. Commoners will never see a tangible dime out of the med device. That's the plan how I read it in the AIF - About Insiders First

GL2ALL

/////AMG